Introduction
In Germany -similar to most other European countries -the proportion of over 65-year-old was 5% in 1910 and has tripled to 14.6% in 1985. For 2000 this proportion represented 17.1% of the population and will increase to 27% by 2030. 1 This demographic trend greatly affects the number of elderly patients that will present with epileptic seizures since the incidence of epilepsy is increasing with age. 2 In fact, contrary to former views the incidence rate of epilepsies after the age of 65 years is higher than in childhood and adolescence and epileptic seizures are one of the most common neurological problems in the elderly. 3 Given that epilepsy does not increase mortality in elderly patients, the overall increased number of elderly people and the higher incidence of epilepsy in the elderly population will increase the prevalence of epilepsy. 4, 5 Antiepileptic drugs (AEDs) are the primary treatment for epilepsy, although they are prescribed for other conditions. In two community based European studies, the prevalence of epilepsy and AED treatment were both close to 1%. 7, 8 Among nursing home (NH) residents in the US, however, the prevalence of seizures or epilepsy is between 5 and 8% while AEDs are taken by roughly 10%. [9] [10] [11] [12] AEDs may be of considerable risk for the elderly due to falls, cognitive side effects, adverse events, and drug interactions. [13] [14] [15] . In addition, inappropriate AED use has a significant impact on public health costs leading to increased hospitalisation and mortality. 16 Given the lack of studies from Europe, the purpose of this study was to provide preliminary evidence on the frequency of AED use in NH residents in a mid-western region in Germany.
Methods

Study design
This was a cross-sectional pharmacoepidemiological study of the use of one and more AEDs by NH residents in the area around the city of Mainz, Rhineland-Palatinate, Germany. The institutional review board and the executive officers at each participating facility approved all procedures and subjects or legal guardians gave written and informed consent according to the Declaration of Helsinki. 17 Subject's identity was masked before data transfer.
Study cohort
All nursing homes in the city of Mainz (n = 2263 residents in 15 NH), the counties of Mainz-Bingen (n = 1028 in nine NH) and Bad Kreuznach (n = 1480 in 14 NH), and in the cities of Wiesbaden (n = 2180 in 22 NH) and Frankfurt/Main (n = 4239 in 35 NH) were asked to participate in this study by written mail (n of residents in all NH facilities n = 11,190). Of these six NH agreed to participate compromising a sample size of 565 residents (5.05% of all residents in the area).
The use of AEDs, residents characteristics, and medical data from all subjects were gathered from two data sources: the electronically recorded prescriptions and physician orders from the pharmacies supplying the participating NH and by reviewing patients records and all available medical information at an on-site visit at a given test day in those patients taking AEDs. AEDs consisted of all on the German market licensed AEDs at the time of data collection. The following data were collected from medical and nursing records in all patients who took AEDs on a regular basis (>4 weeks): demographic data; level of care (according to German law classified as grade 1 (needs help once per day in activities of daily living (ADL), 2 (three times help/day in ADL) and 3 (permanent help in ADL)); weight in kilograms; diagnosis and indication for AED intake; number, type, daily dose and dose allocation in mg of AEDs; AED serum levels; other concurrent medical diagnosis; the total number of drugs other than AEDs and specifically if anti-coagulants such as phenprocoumon were used.
Statistical analysis
This was a cross-sectional study and the unit of analysis was the individual patient receiving therapy with AEDs. Percentages, the mean and median with standard errors or standard deviations were used to summarize baseline information for all variables. For comparisons between data of the sample taking AEDs and data of all residents in the participating NH chisquare and two-sided t-statistics assuming unequal variance were used considering a p-value < 0.05 as statistical significant.
Results
Residents in the participating nursing homes (n = 565) were on average 82.2 (AE2.4 S.D.) years old, 85.5% were women and 14.5% men. They did not need help in ADL in 7.4% or were care-level 1, 2, and 3 in 28.7, 38.7, and 28.1%, respectively. Of the participating residents (n = 565), 4.96% (n = 28) used at least one AED. Data of the residents taking AEDs are based on 27 cases, because one patient did not give his consent. Average age of patients taking AEDs was 79.3 (AE1.7) years and did not differ significantly from all residents. Sex distribution (5 (18.5%) male and 22 (81.5%) female) and the level of care was not significantly different compared to all residents (level 0:3.7%, level 1:18.5%, level 2:55.6%, and level 3:22.2% in those on AEDs). The three most commonly used AEDs were carbamazepine (CBZ 37.1%), sodium valproate (VPA 25.9%) and phenytoin (DPH 14.8%). Average dosages (AES.D.) were 465 AE 268, 810 AE 571, and 360 AE 140 mg for CBZ, VPA, and DPH, respectively. AEDs intake occurred four times daily in n = 3, three times daily in n = 7, twice per day in n = 11, and once per day in n = 6 patients. Newer generation AEDs were used by 14.8% and benzodiazepines (clonazepam, diazepam, lorazepam) by 18.5% of patients. Most patients (n = 21, 77.7%) used one AED, four used two, and one patient three AEDs. No resident had orders or prescriptions for four or more AEDs at one time. In no patient except one, in whom serum levels were determined 2 years prior to the study-serum levels of AEDs were documented in the records. Patients on average used 5.6 AE 0.6 (range 0-15, median 5) other drugs apart from AEDs and no patient on AEDs took phenprocoumon.
Epilepsy or epileptic seizures were the most common indications for AED use (17 of 27 patients (63%)). However, in 7.4% of patients AEDs were used because of one single epileptic seizure. In 29.6% (n = 8) of patients AED use was unclear because neither were epileptic seizures documented nor could a history of seizures be obtained from patients, care takers, or guardians. In addition, there was no other medical condition justifying AED use in these patients. Concurrent other medical diagnoses were cerebral vascular disease (55.6%), dementia (14.8%), intercerebral haematoma (14.8%), and other nonneurological conditions (14.8%). In 18.6% of patients no diagnosis other than epilepsy was recorded.
Discussion
This small preliminary study analysed the number of AEDs taken by patients in six nursing homes around the City of Mainz, Germany. Results show that AEDs were not indicated in more than 30% of patients, benzodiazepines were used more often in NH to control seizures than newer generation AEDs andin contrast to studies from the US -carbamazepine and sodium valproate were the two most commonly used drugs. This study is in line with reports of inappropriate medication use among elderly living in nursing homes, which has been documented in up to 40% in studies from the US and Canada and seems to be a common problem also in Europe. [18] [19] [20] Long-term use of long-acting benzodiazepines like diazepam, clonazepam and of barbiturates, may be of concern because these drugs have a long half-life in elderly patients (often several days), producing prolonged sedation and increasing the risk of falls and fractures. 21 It is of note that in the present study both these types of drugs were used more often than the newer generation AEDs, which cause less sedation, are better tolerated, have a favourable pharmacokinetic profile, and are therefore, recommended in particular in the elderly. 15, 22 The dosages prescribed to our patients were as low as excepted from doubleblind studies in the elderly except for phenytoin which was prescribed at an unusually high dose. 22, 23 Of note, one third of residents took AEDs more frequently than necessary, i.e. three times or more often per day, which may impact negatively on compliance.
Comparable studies of AED use in nursing homes in the US revealed that AEDs are used by about 10% of residents, phenytoin being the most commonly used AED. 9, 11 The more frequent use of carbamazepine and sodium valproate in the present study might reflect the current custom of AED prescription in Germany in adult patients with focal epilepsy. There is, to our knowledge, only one comparable European study about the use of AEDs in patients receiving long-term care. 24 In the study by Timmons et al. 24 31 of 182 (17%) patients used AEDs and the order of frequency was carbamazepine (45%), phenytoin (29%), and sodium valproate (23%). 24 We could not confirm the findings by Timmons et al. that AEDs were more often prescribed to males and individuals below the age of 80 years. 24 Treatment with AEDs should be based on a clear diagnosis. In the present report diagnosis and indication was unclear in about one third of patients. In addition, in the minority of patients the epileptic syndrome was defined. Therefore, this study argues for the need for more extensive studies about the health-care provisions regarding the recognition and treatment of epilepsy in the setting of care facilities.
Conclusions
This study suggests that antiepileptic drugs are given less often to nursing home residents in Germany compared to the US. However, AEDs are often prescribed without a clear diagnosis and AEDs with an unfavourable adverse event and pharmacokinetic profile prevail. The education of physicians working with geriatric epilepsy patients needs to be improved.
